Evidence map›Paper›PMID 35403941›Full record

ArticleMolecular biology reports2022

Hb New York, preliminary results concerning the hematologic characteristics and the effects on thalassemia.

Zhuru Cheng, Xiaonian Zhu, Dan Zeng, Qiao Feng, Baodong Tian, Haiqing Zheng, Shengkui Tan, Chunjiang Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhuru Cheng *Department of Genetics, The Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, People's Republic of China.
Xiaonian Zhu *Department of Epidemiology and Health Statistics, School of Public Health, Guilin Medical University, Guilin, 541199, Guangxi, People's Republic of China.ORCID http://orcid.org/0000-0002-6175-3204
Dan ZengDepartment of Genetics, The Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, People's Republic of China.
Qiao FengDepartment of Genetics, The Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, People's Republic of China.
Baodong TianDepartment of Genetics, The Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, People's Republic of China.
Haiqing ZhengDepartment of Genetics, The Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, People's Republic of China.
Shengkui TanDepartment of Epidemiology and Health Statistics, School of Public Health, Guilin Medical University, Guilin, 541199, Guangxi, People's Republic of China.
Chunjiang ZhuDepartment of Genetics, The Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, People's Republic of China. zcjiang2003@qq.com.
Guilin Medical University · CN

Funding

National Natural Science Foundation of China 82060037Natural Science Foundation of Guangxi Province 2018JJA140062
6 · The paper itself

Abstract

backgroundThe hematological phenotype and genotype analysis of hemoglobin New York (Hb New York) combined with α or β thalassemia has been rarely reported, and whether there is any effect of Hb New York on thalassemia has not been well explored. METHODS AND

resultsIn this study, peripheral blood samples from 346 Hb New York carriers were collected for blood cell parameter analysis. When comparing Hb New York heterozygotes, Hb New York combined with α

conclusionsOur study shows that the hematological characteristics of Hb New York combined with thalassemia are similar to the corresponding thalassemia, and Hb New York does not aggravate the clinical manifestations of thalassemia.

Indexed as

alpha-Thalassemiabeta-ThalassemiaHemoglobins, AbnormalHeterozygoteHumanshemoglobin New YorkHemoglobins, AbnormalAbnormal hemoglobinHb New YorkHematological phenotypeThalassemia

Identifiers

PMID35403941
OpenAlexW4223423572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.